What did TRUSCREEN GROUP LIMITED announce?

TRUSCREEN GROUP LIMITED (NZX: TRU) filed “TruScreen Shareholder Update” with NZX on 11 October 2026, as an operational update announcement.

When was it filed?
11 October 2026
Where is the original?
NZX announcement
TRUSCREEN GROUP LIMITED logo

TruScreen Shareholder Update

Operational Update11 October 2026TRUIndustrials

TRUSCREEN.COM
truscreen.com

BEYOND

SCREENING

TruScreen’s news from

around the globe

OCTOBER 2026

Follow us: Get in touch: info@truscreen.com

TRUSCREEN FEATURED AT WHO CO-HOSTED

AFRICA HEALTH CARE SUMMIT

Summit hosted in Rwanda and co-hosted by the World Health Organisation

(WHO), Africa Centres for Disease Control and Prevention (Africa CD) and Smart

Africa


TruScreen’s Rwandan representative, Charles Nshimiyimana of Biotech Medical

Supply (BMS) was invited to present TruScreen at the Cervical Cancer plenary session

of the Africa Health Tech Summit held in Kigali from 30 Sep-2 Oct. The summit brought

together more than 4,000 delegates from across Africa and beyond, including

government leaders, health professionals, technology innovators, investors and key

Non Government and Government organisations including WHO and Africa CDC, and

Ministry of Health officials from across Africa.


As well as presenting at the Plenary Session, Charles met the Rwanda Minster of

Health Dr Sabin Nzanzimana and discussed TruScreen with him. The Minister has

arranged for two key Medical Advisors from his department to introduce TruScreen to

their Expert Panel, and BMS is also organizing a meeting with Rwanda Biomedical

Centre (RBC), the organization that implements the public health programs of

Rwanda.

TRUSCREEN.COM
truscreen.com

TruScreen CEO Keynote Speaker at inaugural Kenya-Australia

Trade and Investment Summit

TruScreen African Footprint Expanded with Appointment of

Distributor for Kenya, Somalia and South Sudan

On 11 September, TruScreen CEO Marty Dillon was an invited keynote

speaker at the Inaugural Kenya-Australia Trade and Investment Summit

in Sydney. Guests included the Kenya High Commissioner, Federal and

NSW cabinet members, business and academic leaders and members of

the Kenyan Community - including the Hon Bishop Jackson Kipkemoi

Kosgei MP (Head of Delegation) and Hon Beatrice Chepng’eno Kemei MP

who has a mandate that includes advocacy on gender equality, youth,

children, social protection and community-development.


Following quickly from the Summit, TruScreen expanded its African

footprint with the appointment of Ansell Pharmaceuticals Limited as our

distributor for Kenya, Somalia and South Sudan. Ansell’s 25 member

team is experienced in the supply of pharmaceuticals and medical

devices to NGOs, including WHO and the UN, for NGO funded public

health programs in East Africa.

EAST AFRICA

ZIMBABWE

OCTOBER 2026

Follow us: Get in touch: info@truscreen.com

TruScreen is still under consideration for several major grants and programs. The largest of these are the Clinton Health Access Initiative

application covering Sub-Saharan Africa and the UNITAID application (championed by a leading African NGO) also for Sub-Saharan Africa. In

addition TruScreen is awaiting the outcome of a Nigeria-specific application for the Beginning Investigator Grant for Catalytic Research (BIG Cat),

supported by American Association for Cancer Research, submitted by Dr Ayokunle Olumodeji from Lagos State University Teaching Hospital

who is assisting in the preparation of applications for two more grants for programs in Nigeria.

L-R: Associate Professor David Mickler, Curtin University; His Excellency

Ambassador Dr Wilson Kogo, Kenya High Commissioner to Australia;Hon.

Anoulack Chanthivong, MP, Minister for Industry and Trade, Minister for

Innovation, Science and Technology, NSW; Marty Dillon

L-R: Marlene Ayiro, Principal Legal Counsel – Kenya National Assembly;

Timothy Kipchumba Toroitich MP Marakwet West Constituency; Beatrice

Chepngeno Kemei MP, Woman Representative Kericho County; Marty

Dillon; Ruth Nduta Kamau, Organising Committee

Following much bureaucratic wrangling, the year’s first

screening program for 10,800 women in Masvingo

Province is expected to commence in 16 public

hospitals in November 2026, with a second program

already in discussion with our distributor.

AFRICAN GRANT APPLICATIONS

NEWS FROM AROUND THE GLOBE....

TRUSCREEN.COM
truscreen.com

OCTOBER 2026

Follow us: Get in touch: info@truscreen.com

China’s South and West China Rollout Strategy begins

TruScreen’s China distributor, SiWeiXaingTai Technology (SWXT) has commenced a

major campaign to bring TruScreen to key Southern and Western markets. Especially

important is their focus on Sichuan province which now serves as the national role model

for Gynaecological products inclusion in national public hospital catalogues. The lead

gynaecologist in Sichuan province is a significant supporter of TruScreen and was

involved in the landmark COGA study which demonstrated TruScreen’s superiority as a

cervical cancer screening technology. The West China Second University Hospital of

Sichuan University, the most prominent gynaecology centre in Sichuan and one of the

best OBGYN hospitals in the country, is preparing a formal submission for TruScreen to

be included in the public hospital catalogue.


In the South, Guangdong Province is the most important market for TruScreen’s growth.

In October, our distributor SWXT will sponsor the key OBGYN conference in Shantou City,

and one of the major hospitals in the province, The Third Affiliated Hospital, Sun Yat-sen

University, will start a clinical study on TruScreen involving 500 women. SWXT’s activities

are bearing fruit as two new hospitals have recently received approval to install

TruScreen and a further two key hospitals have applied for and are awaiting approval to

install TruScreen.


In the North in Jilin Province, TruScreen has been included in the provincial hospital

catalogue and attained pricing approval. This will support the Sichuan application by

acting as another strong reference for national catalogue inclusion, which will accelerate

TruScreen’s national roll out in China.

CHINA

TruScreen’s clinical validation program in Tashkent

has been completed and preliminary results have

been reported as ‘very good’. Final publication of

the results will clear the path for public health

adoption of TruScreen in Uzbekistan.


Following this news Albatros Health Care LLC,

TruScreen’s distributor in Uzbekistan has placed

their first order of 2,160 SUS, to be delivered this

month.

UZBEKISTAN

NEWS FROM AROUND THE GLOBE....

In addition to the Shariaptur Development Society grant application
featured in our last newsletter, TruScreen’s local distributor in Bangladesh -

Xerox Medica Ltd - has engaged in talks with the Bangladesh Ministry of

Health regarding additional programs utilising TruScreen’s unique AI

enabled technology. The proposed projects will be funded by the

Bangladesh government and NGO’s including the World Bank and the Asia

Development Bank.

Nova Biointermedicx Pvt Ltd has been appointed as the TruScreen

distributor for Nepal. Nova Biointermedicx has extensive connections across

Nepal’s Central and Provincial governments. Nova selected TruScreen as

their preferred technology after comparing TruScreen to competitors for

cervical cancer screening available on the local market, and chose

TruScreen to participate in the upcoming government tender which opens in

November. Nova is adamant that TruScreen offers the ideal solution to the

problems in cervical cancer screening in Nepal where the government is

striving to achieve the 70% screening coverage goal committed with WHO.

A cohesive strategic approach is being developed for TruScreen

expansion across the Indian subcontinent, with TruScreen

executive Sumaya Mozumder taking on the role of TruScreen’s

dedicated regional account manager. We have been working with

Austrade to build key relationships in the region with our Indian

distributor, Renovate Biologicals, as well as exploring collaborative

opportunities with major NGOs including PATH (Program for

Appropriate Technologies in Health) in India. Indian product

registration is expected to be obtained in October or November,

with our distributor Renovate Biologicals preparing for an imminent

product launch in the worlds most populous country and fourth

largest economy

OCTOBER 2026

NEWS FROM AROUND THE GLOBE....

Follow us:

truscreen.com

Get in touch: info@truscreen.com

INDIAN SUBCONTINENT EXPANSION

BANGLADESH

NEPAL

TruScreen has saved over
72,000* lives - enough to fill an

international football stadium.

Dr Carolina Velasquez holds a Bachelor of Medicine and Surgery

from Pontificia Universidad in Colombia and a Masters in Clinical

Research from Monash University in Melbourne.


Multi lingual, she has 8 years experience with TruScreen

conducting and supervising clinical trials in Australia, India,

Zimbabwe, China, Vietnam, Indonesia and Mexico as well as

overseeing all TruScreen user training across the globe.

Dr Velasquez also co-ordinates the work of both Truscreen's

Medical Advisory Committee and international Medical Experts

Group.

That’s the number of women who have received

an abnormal TruScreen result and been referred

for triage or treatment before their disease could

silently progress to cancer.

*based on an average global abnormality rate of 6%.

Learn more about:

Dr Carolina Velasquez MBBS, M ClinRes

TruScreen’s Medical Affairs and Training Manager

NEWS FROM HQ...

truscreen.com

DID YOU KNOW?

OCTOBER 2026

Follow us: Get in touch: info@truscreen.com

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.